LifeStance Health Group, Inc. 8-K

What Happened LifeStance Health Group, Inc. filed an 8‑K reporting the results of its annual meeting of stockholders held June 2, 2026. Stockholders elected two Class II directors for three‑year terms, ratified PricewaterhouseCoopers LLP as the independent auditor for 2026, and approved (non‑binding) the company’s named executive officer compensation.

Key Details

• Directors elected (Class II, three‑year terms):
  • David Bourdon: For 244,968,319; Withhold 83,966,052; Broker non‑votes 29,782,714.
  • Robert Bessler: For 280,015,618; Withhold 48,918,753; Broker non‑votes 29,782,714.
• Auditor ratification: PricewaterhouseCoopers LLP ratified for 2026 — For 357,756,707; Against 209,431; Abstain 750,947.
• Advisory vote on executive pay (non‑binding): For 322,904,359; Against 5,675,861; Abstain 354,151; Broker non‑votes 29,782,714.

Why It Matters These voting outcomes confirm the board composition and corporate governance direction for the next three years, keep PwC as the company’s auditor for the 2026 fiscal year, and show strong shareholder support for the company’s executive compensation program (advisory vote). Investors should note the vote totals and broker non‑votes when assessing shareholder consensus and potential governance or proxy issues.